2016 European Guidelines on cardiovascular disease prevention in clinical practice
Arno Wilhelmus Hoes, Christian Albus, Carlos Brotons, Alberico Luigi Catapano, Marie Therese Cooney, Ugo Corrà, Bernard Cosyns, Christi Deaton, Ian M Graham, Michael Stephen Hall, Richard F. Hobbs, Maja‐Lisa Løchen, Herbert Löllgen, Pedro Manuel Marques-Vidal, Joep Perk, Eva Prescott, Josep Redón, Dimitrios J. Richter, Naveed A. Sattar, Yvo Michiel Smulders, Monica Tiberi, H. Bart van der Worp, Ineke van Dis, W. M. Monique Verschuren, Oscar H. Franco, Borut Jug, Kornelia Kotseva, Alessandro Mezzani, Alexander Niessner, Guillaume Turc, Olov Wiklund, Victor Aboyans, Stefan Agewall, Lina Badimón, Gonzalo Barón‐Esquivias, Jeroen Joost Bax, Çetin Erol, Philippe H. Kolh, Gregory Y.H. Lip, Massimo Francesco Piepoli, Adam Torbicki, Ruslan Najafov, Ivan Tomov Gruev, H Vaverková, Jean Ferrières
European Heart Journal · 2016 · 6,764 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., Graham, I. M., Hall, M. S., Hobbs, R. F., Løchen, M., Löllgen, H., Marques-Vidal, P. M., Perk, J., Prescott, E., Redón, J., … Hambrecht, R. (2016). 2016 european guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal, 37(29), 2315–2381. https://doi.org/10.1093/eurheartj/ehw106
In text: (Piepoli et al., 2016)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the population level or targeted at an individual, that are aimed at eliminating or minimizing the impact of CVDs and their related disabilities.1 CVD remains a leading cause of morbidity and mortality, despite improvements in outcomes. Age-adjusted coronary artery disease (CAD) mortality has declined since the 1980s, particularly in high-income regions.2 CAD rates are now less than half what they were in the early 1980s in many countries in Europe, due to preventive measures including the success of smoking legislation. However, inequalities between countries persist and many risk factors, particularly obesity3 and diabetes mellitus (DM),4 have been increasing substantially. If prevention was practised as instructed it would markedly reduce the prevalence of CVD. It is thus not only prevailing risk factors that are of concern, but poor implementation of preventive measures as well.5,6 Prevention should be delivered (i) at the general population level by promoting healthy lifestyle behaviour7 and (ii) at the individual level, i.e. in those subjects at moderate to high risk of CVD or patients with established CVD, by tackling unhealthy lifestyles (e.g. poor-quality diet, physical inactivity, smoking) and by optimising risk factors. Prevention is effective: the elimination of health risk behaviours would make it possible to prevent at least 80% of CVDs and even 40% of cancers.
Related papers
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement2009
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report2003
- The National Comprehensive Cancer Network1998
- Standardisation of spirometry2005
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science2009
Metadata from OpenAlex (CC0). Citations are generated from the published record.